NCT00729001View on ClinicalTrials.gov

Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.

PHASE2CompletedINTERVENTIONAL
Enrollment

529

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
Infections, Rotavirus
Interventions
BIOLOGICAL

Human Rotavirus Vaccine - two different formulations

Two oral doses

BIOLOGICAL

Prevnar

Three-dose intramuscular injection (US subjects only)

BIOLOGICAL

IPOL

Two-dose intramuscular injection (US subjects only)

BIOLOGICAL

Infanrix

Three-dose intramuscular injection (US subjects only)

BIOLOGICAL

OmniHIB

Three-dose intramuscular injection (US subjects only)

BIOLOGICAL

Pentacel

Three-dose intramuscular injection (Canada only)

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY